Menu Menu


GSK Financials       Clear


GSK        0001131399    
Filing Date Form Type Description Document
2021-07-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-23 6-K BOARD COMMITTEE CHANGES View Document
2021-07-22 6-K CEO DESIGNATE OF NEW CONSUMER HEALTHCARE COMPANY View Document
2021-07-16 6-K GSK ANNOUNCES DAPRODUSTAT PHASE 3 HEADLINE RESULTS View Document
2021-07-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-12 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2021-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-07-06 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP View Document
2021-07-02 6-K GSK AND ALECTOR COLLABORATION IN IMMUNO-NEUROLOGY View Document
2021-07-02 6-K ELLIOTT ADVISORS (UK) LETTER TO GSK View Document
2021-07-01 6-K TOTAL VOTING RIGHTS View Document
2021-06-25 11-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE View Document
2021-06-25 11-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE View Document
2021-06-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES View Document
2021-06-23 6-K GSK TO DELIVER STEP-CHANGE IN GROWTH & PERFORMANCE View Document
2021-06-22 6-K VIIV/HALOZYME SIGN EXCLUSIVE LICENSING AGREEMENT View Document
2021-06-17 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES View Document
2021-06-14 6-K GSK AND ITEOS ANNOUNCE COLLABORATION FOR EOS-448 View Document
2021-06-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-04 6-K TRC CAPITAL LETTER View Document
2021-06-01 6-K TOTAL VOTING RIGHTS View Document
2021-05-27 SD SD View Document
2021-05-27 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-27 6-K SANOFI AND GSK INITIATE NEW PHASE 3 CLINICAL STUDY View Document
2021-05-27 6-K GSK/VIR SOTROVIMAB FDA EMERGENCY USE AUTHORIZATION View Document
2021-05-25 SC 13D/A AMENDED SCHEDULE 13D View Document
2021-05-24 4 CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-05-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-21 6-K GSK/VIR SOTROVIMAB RECEIVES POSITIVE EMA OPINION View Document
2021-05-18 6-K BLOCK LISTING INTERIM REVIEW View Document
2021-05-18 6-K MEDICAGO/GSK COVID-19 VACCINE POSITIVE PH2 RESULTS View Document
2021-05-17 6-K SANOFI/GSK COVID-19 VACCINE POSITIVE PH2 RESULTS View Document
2021-05-14 25-NSE View Document
2021-05-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-11 6-K EMTN PROSPECTUS View Document
2021-05-06 6-K BOARD AND COMMITTEE CHANGES View Document
2021-05-05 6-K RESULT OF AGM View Document
2021-05-04 6-K TOTAL VOTING RIGHTS View Document
2021-04-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-28 6-K 1ST QUARTER RESULTS View Document
2021-04-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-23 6-K EU APPROVES GSK'S JEMPERLI (DOSTARLIMAB-GXLY) View Document
2021-04-23 6-K FDA APPROVES GSK'S JEMPERLI (DOSTARLIMAB-GXLY) View Document
2021-04-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-04-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-04-08 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-04-06 6-K DIRECTORATE CHANGE View Document
2021-04-01 6-K TOTAL VOTING RIGHTS View Document
2021-03-30 6-K PUBLICATION OF 2021 AGM NOTICE View Document
2021-03-30 6-K GSK RESPIRATORY PRODUCT SALES REPORTING CHANGES View Document
2021-03-26 F-3ASR F-3ASR View Document
2021-03-24 6-K MONCEF SLAOUI DEPARTS GALVANI BIOELECTRONICS View Document
2021-03-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-17 6-K CHAIR OF AUDIT & RISK COMMITTEE View Document
2021-03-16 6-K MEDICAGO AND GSK START PHASE 3 TRIAL View Document
2021-03-15 F-6 POS View Document
2021-03-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-15 6-K ANNUAL REPORT 2020 ON FORM 20-F View Document
2021-03-12 IRANNOTICE IRANNOTICE View Document
2021-03-12 20-F 20-F View Document
2021-03-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-11 6-K GSK AND VIR SHARE POSITIVE VIR-7831 DATA IN COVID View Document
2021-03-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-09 6-K ANNUAL FINANCIAL REPORT View Document
2021-03-02 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-03-01 6-K TOTAL VOTING RIGHTS View Document
2021-02-25 6-K GSK ANNOUNCES OTILIMAB DATA FOR TREATMENT OF COVID View Document
2021-02-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-24 6-K HOLDING(S) IN COMPANY View Document
2021-02-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-22 6-K SANOFI AND GSK INITIATE NEW PHASE 2 STUDY View Document
2021-02-19 4 CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-17 6-K GSK/VIR COLLABORATE ON ANTIBODIES FOR INFLUENZA View Document
2021-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-02-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas